MarketPulse

regulatory uncertainty

2 articles
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Tilray's Revenue Gains Mask Deeper Problems: Why Skeptics Remain Unconvinced

Tilray posts record $217.5M quarterly revenue and narrows losses, but persistent negative cash flow and competitive headwinds keep investors wary.
TLRYrevenue growthcannabis stocks
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

HCA Healthcare Posts Strong Quarter Amid Mixed 2026 Outlook

HCA Healthcare reported strong Q4 2025 results with 6.7% revenue growth, but guided for slower 3.5% growth in 2026 due to ACA credit expiration and regulatory uncertainty.
HCAearnings growthhealthcare stocks